Radiomics Profiling Identifies the Incremental Value of MRI Features beyond Key Molecular Biomarkers for the Risk Stratification of High-Grade Gliomas

<div>Decision curve analysis for the clinical-genetic model, radiomics model, and combined model. The <i>y</i>-axis represents the net benefit, and the <i>x</i>-axis represents the threshold probability.</div>

Contrast Media & Molecular Imaging

fig11

Figure 11

Figure 11: Radiomics Profiling Identifies the Incremental Value of MRI Features beyond Key Molecular Biomarkers for the Risk Stratification of High-Grade Gliomas 

Figure 11 | Radiomics Profiling Identifies the Incremental Value of MRI Features beyond Key Molecular Biomarkers for the Risk Stratification of High-Grade Gliomas 